Literature DB >> 6602679

Reactivity of low molecular weight material in cellular immune complex assays.

K M Cooper, M Moore.   

Abstract

A major difference in molecular size of material reactive in the C1q binding assay and two cellular assays (Raji and L1210) for immune complexes, is reported. Elevated C1q binding of pathological sera was associated with material in the range 7-19S, as determined by Sepharose 6B chromatography of sera from patients with chronic inflammatory and neoplastic lung diseases. By contrast, reactivity of identical sera in the Raji and L1210 assays was linked predominantly with material of molecular size 7S. Dissociation of immune complexes on storage and/or in consequence of the chromatographic procedure was effectively discounted. Furthermore, differential binding of 7S IgG fractions tested at a standard concentration indicated that reactivity in either test was not attributable to non-specific binding of IgG. In a previous study, saturation of FcR (on L1210 and Raji) and C3R (on Raji only) by heat-aggregated IgG failed to distinguish whether binding directly involved these receptors or other cell surface components. In the present investigation, no firm correlations emerged between reactivity in the two tests and possible candidate antibodies reactive with cell surface components such as anti-lymphocyte and anti-nuclear antibodies. It is therefore suggested that low molecular weight binding may be attributable to more than one factor including 7S IgG (immune complex dissociated, or otherwise), autoantibodies, IgG-C3 complexes and possibly very small immune complexes (Ag1, Ab1). The assumption that Raji and L1210 and possibly other cellular assays detect only high molecular weight immune complexes is questionable and the need for further characterization of other reactive material is emphasized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602679      PMCID: PMC1535839     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

Review 4.  Current knowledge and concepts of the relationship of malignancy, autoimmunity, and immunologic disease.

Authors:  G J Friou
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

5.  Characterization of immune complexes in serum by adsorption on staphylococcal protein A: model studies and application to sera of rats bearing a gross virus-induced lymphoma.

Authors:  D F Tucker; R H Begent; N M Hogg
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

6.  The L1210 radioimmune assay for detecting circulating immune complexes.

Authors:  T R Poskitt; P K Poskitt
Journal:  Immunol Commun       Date:  1978

7.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Factors relating to circulating immune complexes in rheumatoid arthirits.

Authors:  P J Roberts-Thomson; B L Hazleman; I G Barnett; I C MacLennan; A G Mowat
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

10.  Detection of circulating immune complexes in patients with glomerulonephritis.

Authors:  A J Woodroffe; W A Border; A N Theofilopoulos; O Götze; R J Glassock; F J Dixon; C B Wilson
Journal:  Kidney Int       Date:  1977-10       Impact factor: 10.612

View more
  3 in total

1.  Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.

Authors:  S S Levinson; J O Goldman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

2.  Fluorescent anti-immunoglobulin G assay of circulating immune complexes extracted with polyethylene glycol.

Authors:  S S Levinson; J Goldman
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; S Lobatto; E A van der Voort; F C Breedveld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.